Copenhagen Center for Glycomics collaborates with Desktop Genetics to analyze their novel CRISPR assay

London, UK — Copenhagen Center for Glycomics (CCG) and Desktop Genetics (DTG) today announced a collaboration to develop the next-generation of CRISPR analysis. The project is designed to provide a deeper understanding of a novel method of identifying nuclease-generated mutations developed by the lab of Dr. Eric Paul Bennett. The method is currently used by CCG and [...]

Bertin and Zymo Research Announce New Collaboration

Bertin’s Precellys® Evolution Homogenizer and Zymo Research’s ZymoBIOMICS® Microbial Community Standard: Liberation of DNA From all Microbes in Just One Minute IRVINE, Calif. & ROCKVILLE, Md.--Zymo Research Corp. and Bertin announce a collaboration that ensures the sample lysis step in the microbiome workflow is complete and unbiased. An application note is available describing the materials, procedure and results attained [...]

New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes

Oncomine Myeloid Research Assay leverages Thermo Fisher's next-generation sequencing to analyze 74 genes in a single panel and overcome hurdles of sequential-based clinical research CARLSBAD, Calif. -- Clinical researchers interested in studying driver mutations suspected in hematological malignancies now have access to a new targeted next-generation sequencing (NGS) research panel for simultaneous analysis of 74 relevant genes. [...]

David Ray Named President of FLIR Systems’ Government & Defense Business Unit

WILSONVILLE, Ore. -- FLIR Systems, Inc. (NASDAQ:FLIR) today announced that David Ray has been named President of the Government & Defense Business Unit, effective January 8th, 2018. Reporting to FLIR President and CEO, Jim Cannon, Mr. Ray will be responsible for leading all aspects of the Government & Defense business unit, including strategy, R&D, operations, business development, and marketing. David Ray, new President of FLIR Government and [...]

Sartorius Stedim Biotech Launches New Versions of Data Analytics Software Solutions

SIMCA® and SIMCA®-online software updates in the Umetrics™ Suite help manufacturing industries make better business decisions and optimize process control Goettingen, Germany and Malmö, Sweden -- Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has introduced a new version of its SIMCA® and SIMCA®-online data analytical solutions, which are offered by its subsidiary [...]

Rigaku Analytical Devices Announces Fentanyl Library Additions to Progeny ResQ Handheld Raman Analyzer

Wilmington, MA – Rigaku Corporation is pleased to announce that Rigaku Analytical Devices, a leading provider of innovative handheld Raman spectrometers, has announced a library update in its Progeny ResQ software giving users the ability to identify more opioids, including various fentanyl compounds. Designed with customer needs in mind, the Progeny™ ResQ 1064nm handheld Raman analyzer provides the industry’s most comprehensive [...]

Shimadzu Scientific Instruments and Restek Corporation Announce Distribution Agreement

COLUMBIA, MD — Shimadzu Scientific Instruments (SSI) and Restek Corporation have entered a partnership that enables the sales of Restek consumables by SSI. Under the terms of this agreement, SSI will promote and sell Restek consumables throughout its geographic territory, which includes the United States, Latin America, and the Caribbean.   Through this partnership, SSI will [...]

STEMBIOSYS ANNOUNCES NEW EUROPEAN DISTRIBUTOR FOR STEM CELL RESEARCH PRODUCTS

SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with Caltag Medsystems Ltd. to distribute and market StemBioSys products. Caltag will distribute StemBioSys products in the European Union. Initially, the agreement will cover StemBioSys’ cell expansion products, but as additional products are added to StemBioSys’ portfolio in the future, these [...]

CMS Issues Proposed National Coverage Determination of NGS IVDs Including Thermo Fisher Scientific’s Oncomine Dx Target Test

The proposed national coverage determination provides Medicare beneficiaries with reimbursable testing using multi-biomarker NGS IVD tests to better inform treatment decisions CARLSBAD, Calif. -- The Centers for Medicare & Medicaid Services (CMS) has proposed coverage for the Oncomine Dx Target Test as part of a national coverage determination (NCD) for next-generation sequencing (NGS) in vitro diagnostic (IVD) tests. Once [...]

PARTNERSHIP BETWEEN JPK INSTRUMENTS & CYTOSURGE – MAKING FLUIDFM® AVAILABLE ON THE JPK NANOWIZARD® AFM PLATFORM.

Zurich / Glattbrugg | Cytosurge, a Swiss company that develops and distributes scientific measuring instruments and robotic systems based on its patented FluidFM® technology, and JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, announce their partnership. Thanks to this partnership, JPK’s NanoWizard® AFM users will now be [...]

Access IBO on Knowledge Center